Auxilium Health

Auxilium Health is a private U.S. wound-care biomaterials company developing engineered bioaerogel and extracellular-matrix-mimicking materials for hard-to-heal wounds and related regenerative medicine applications. The company says its Aer platform is designed to resist bacterial attachment while supporting regenerative cell growth, aiming to improve infection management and tissue repair without relying on antibiotics. Its lead product is being advanced toward FDA clearance and first-in-human studies, indicating the company is not yet commercial stage. Auxilium also describes broader platform applications in wound repair, bone regeneration, and localized delivery. The company has raised pre-seed and seed financing and has received non-dilutive support from the National Science Foundation and Ohio-based innovation programs.